Research Article
The Association between Serum Level of Vitamin D and Inflammatory Biomarkers in Hospitalized Adult Patients: A Cross-Sectional Study Based on Real-World Data
Table 3
The association between vitamin D and inflammatory biomarkers in 35,528 Chinese adult hospitalized patients.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Notes: Multivariate model was adjusted by sex (men vs. women), age (year), hospital (Ren Ji vs. Xin Hua), season (spring, summer, autumn, or winter), BMI (<18.5 kg/m2, 18.5–23.9 kg/m2, or ≥24.0 kg/m2), anemia (yes vs. no), albumin (<35.0 g/L vs. ≥35.0 g/L), fasting blood glucose (<6.0 mmol/L vs. ≥6.0 mmol/L), serum level of liver enzymes (normal vs. abnormal), cholestasis (yes vs. no), eGFR-EPI (<60.0 vs. ≥60.0 mL/min/1.73 m2), dyslipidemia (yes vs. no), CCI (0, 1–2, or ≥3 points), diet intake (<500 kcal/day, 500–1,000 kcal/day, or ≥1,000 kcal/day). Anemia was confirmed as following: serum hemoglobin <120 g/L in men or <110 g/L in women. Abnormal liver enzyme was confirmed if any of the following: alanine transferase ≥ 120 U/L, or aspartate transaminase ≥ 150 U/L, or alkaline phosphatase ≥ 250 U/L, or gamma glutamyl-transferase ≥ 100 IU/L. Cholestasis was confirmed if either of the following: total bilirubin ≥ 34.2 μmol/L or direct bilirubin ≥ 13.6 μmol/L. Dyslipidemia was confirmed if either of the following: total cholesterol ≥ 5.72 mmol/L or total triglycerides ≥1.7 mmol/L. |